CDC's First Batch of COVID-19 Tests are Flawed? Internal Investigation Reveals Possible Contamination

CDC's first batch of COVID-19 tests is now being criticized after the agency's own internal investigation discovered that they have some issues.

However, after this health tech was released in the United States, the organization started receiving false-positive results from different laboratories.

In the new internal investigation, the flaws positive reactivity of the negative control is believed to come from the N1 component contamination.

This was also detected in the first production lot of the distributed COVID-19 test kits. You can view this link to see more details.

CDC Says the N1 Contamination Leads to COVID-19 Test Enhancements

Based on CDC's statements, the N1 contamination and the design flaws allowed the health agency to enhance further the quality assurance of its RT-CPR and other COVID-19 diagnostic test kits.

The organization added that the changes they made in their health innovation include additional steps of approval and review by health experts, independent of the diagnostic panel design team.

In other news, Moderna's new research shows difficulty when it comes to mRNA flu vaccine development. On the other hand, COVID-19 vaccination data, around 50TB, might have been deleted by hackers targeting the Brazilian Ministry of Health.

For more news updates about COVID-19 and other related health topics, always keep your tabs open here at TechTimes.

This article is owned by TechTimes

Written by: Griffin Davis

ⓒ 2024 TECHTIMES.com All rights reserved. Do not reproduce without permission.
Join the Discussion
Real Time Analytics